ARK Genomic Revolution (ARKG) is a publicly traded Financial Services sector company. As of May 21, 2026, ARKG trades at $29.45 with a market cap of $0 and a P/E ratio of 0.00. ARKG moved +5.25% today. Year to date, ARKG is -1.47%; over the trailing twelve months it is +35.07%. Its 52-week range spans $17.51 to $34.39. Rallies surfaces ARKG's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
ARK Genomic Revolution (ARKG) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. ARKG moved +5.25% today.
| Metric | Value |
|---|---|
| Price | $29.45 |
| Market Cap | $0 |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.38% |
| 52-Week High | $34.39 |
| 52-Week Low | $17.51 |
| Volume | 1.16K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
ARKG analyst coverage data. Average price target: $0.00.